San Diego, CA -- (SBWire) -- 10/31/2022 --The Shareholders Foundation announced that a deadline is coming up on October 31, 2022 in the lawsuit filed for certain investors of Abbott Laboratories (NYSE: ABT).
Investors who purchased shares of Abbott Laboratories (NYSE: ABT) have certain options and there are strict and short deadlines running. Deadline: October 31, 2022. NYSE: ABT stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The plaintiff alleges on behalf of purchasers of Abbott Laboratories (NYSE: ABT) common shares between February 19, 2021 and June 8, 2022, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 19, 2021 and June 8, 2022, the Defendants made numerous materially false and misleading statements and omissions concerning what the U.S. Food and Drug Administration ("FDA") called "egregiously unsanitary" conditions at the Company's Sturgis facility, and that the Defendants repeatedly touted to investors the safety and salability of Abbott's infant formula brands and their contribution to the Company's sales and revenue growth.
Those who purchased shares of Abbott Laboratories (NYSE: ABT) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
About:
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
NYSE: ABT Investor Notice: Deadline on October 31, 2022 in Lawsuit Against Abbott Laboratories
A Deadline is coming up on October 31, 2022 in the lawsuit for certain investors in Abbott Laboratories (NYSE: ABT).